A doctor-guided weight programme, built for women.
Medical assessment first, then a personalised plan with real support and check-ins.
What women on the programme report at check-ins.
From patients' own scheduled check-in forms. Self-reported, not clinical trial data.
Average change reported by month 3
Report a reduced appetite in the first weeks
Find healthier food choices easier on the programme
Say side effects haven't affected their daily life
Patient-reported at scheduled check-ins. Individual results vary. All medicines carry potential risks and side effects.
What does a clinically meaningful change look like for you?
Clinical guidelines describe a 5–10% reduction in body weight as the point at which health markers such as blood pressure, blood glucose and cholesterol typically start to improve. Move the slider to see what that means at your weight.
Regulated supply, or nothing at all.
There's a growing market in South Africa for weight-loss products sold with no prescription, no doctor and no licensed pharmacy behind them - SAHPRA has publicly warned the public about unregistered and illegally sold weight-loss products. FemLab is the opposite of that: prescription-only, doctor-prescribed, dispensed by a licensed pharmacy, with ongoing medical oversight.
Results build over months. Here's the journey.
This isn't a two-week fix. The change comes from staying the course, with your doctor adjusting as you go.
Your body adjusts to a low starting point. Early days — settle in.
Many women report feeling fuller sooner and thinking about food less.
Steady, gradual change as your plan is guided by your doctor where appropriate.
Check-ins keep you on track. The longer you stay, the more it compounds.
Descriptions are general and educational, based on patient-reported experiences on the programme. This is not a prediction of your result. Individual results vary and no specific outcome is guaranteed.
Four steps from here to your plan.
Free 3-minute check
A few questions about your health and history. No cost, no commitment.
A doctor reviews your health
An HPCSA-registered doctor decides what is appropriate — including declining.
Delivered to your door
Where prescribed, dispensed and couriered in plain, unbranded packaging.
Support & check-ins
Dose guidance, side-effect support and reviews the whole way through.
Real reviews from real women.
Femlab
Your questions, answered.
How do I know if I qualify?+
You complete the free check, and a registered doctor reviews your health, history and current medication. The doctor decides whether the programme is clinically appropriate for you — and may decline. Not everyone qualifies.
Will I need blood tests?+
For this treatment no blood tests are required.
Is this the same as buying weight-loss medication online?+
No. This is a doctor-guided programme with medical assessment, personalised next steps and ongoing check-ins. Where treatment forms part of your plan, it is prescribed by a doctor, dispensed by a licensed pharmacy and monitored — never sold to you off a shelf.
Can I do the programme if I'm in perimenopause or menopause?+
Many women on the programme are. Hormonal change affects where and how weight is stored, so the assessment covers it. If your symptoms point primarily to hormones, the doctor may suggest starting there instead.
Can I join if I'm pregnant, breastfeeding or planning a pregnancy?+
Speak to a healthcare professional first — the programme is generally not suitable in these circumstances, and the eligibility check covers it.
How long do I stay on the programme?+
That's a clinical decision made with your doctor at your check-ins, based on how you're responding. There is no fixed minimum term.
Is delivery discreet?+
Yes. Everything is couriered straight to your door.
Find out if the programme is right for you.
A free 3-minute check, reviewed by a registered doctor. If it isn't appropriate for you, we'll tell you.
Sources
References & compliance notes
+
Every factual statement on this page is referenced to a source.
- SAHPRA. Guidelines for Advertisement of Medicines and Health Products, SAHPGL-INSP-RC-07, v2, June 2022. Clause 5.2.2: medicines containing Schedule 2–6 substances may be advertised only for the information of prescribers and pharmacists.
- Republic of South Africa. Medicines and Related Substances Act 101 of 1965, General Regulations, Regulation 42(1)–(2). Only non-prescription medicines may be advertised to the public; public information may cover price, name, pack size and strength but may make no reference to the registered indication.
- World Health Organization. Obesity and overweight fact sheet. Obesity is described as a chronic complex disease.
- National Department of Health, Statistics South Africa, SAMRC and ICF. South Africa Demographic and Health Survey 2016. Prevalence of overweight and obesity among adult women.
- Guideline source for the 5–10% weight-reduction threshold — proposed: SEMDSA / South African obesity management guidance, or WHO/NICE equivalent.
- Health Professions Council of South Africa. General Ethical Guidelines for Good Practice in Telemedicine (Booklet 10). Basis for teleconsultation and doctor registration statements.
- Protection of Personal Information Act 4 of 2013 (POPIA). Basis for the confidentiality statement.
- SAHPRA public communications on unregistered, illegally sold or compounded weight-loss products. [SAHPRA media]